In: Accounting
Everything Equine Corp. (EEC) is a publicly accountable enterprise that specializes in providing horse-related goods and services to horse owners. EEC commenced operations on January 1, 20X2. Select details of transactions with respect to EEC’s property, plant and equipment (PPE) and intangible assets are as follows:
April 1, 20X2
- EEC purchased the PPE of a company in financial distress for $1,800,000 and immediately brought it into use. At the time of purchase, an independent appraiser provided the following valuation of the PPE purchased by the company:
FAIR VALUE | USEFUL LIFE | RESIDUAL | |
LAND | $600,000 | ||
BUILDING | $1,000,000 | 20 YEARS | $100,000 |
EQUIPMENT | $400,000 | 5 YEARS | $0 |
- EEC paid a $32,000 transaction tax to the provincial government relating to the purchase of the land and building. This was a non-refundable tax. EEC also paid its lawyers $9,000 in legal fees for finalizing the purchase agreement for the PPE.
April 1 to June 30, 20X2
- EEC spent $350,000 researching a new horse vaccine and obtained a patent for it.
July 1 to December 31, 20X2
- On July 1, 20X2, EEC determined that the vaccine was commercially viable and met the IFRS requirements for capitalization of development expenses.
- During the remainder of 20X2, EEC spent an additional $450,000
developing the vaccine. The Canadian government was keenly
interested in EEC’s vaccine as it was expected to be very
beneficial to the Canadian equestrian industry, and it provided a
$180,000 grant to EEC to assist with the completion of the
vaccine’s development. The government grant was forgivable once the
vaccine was available for purchase by the public.
January 20X3
- Development of the vaccine was completed and sales commenced in January 20X3. At that time, EEC estimated that the remaining useful life of the vaccine patent was six years.
- EEC spent a total of $80,000 on maintaining and repairing its
equipment. These expenditures were incurred as follows: $10,000 was
for routine maintenance and the remaining $70,000 was for a
replacement part that was expected to extend the useful life of the
equipment by one year.
Other information
- EEC uses the cost model to value its PPE and intangible assets.
It depreciates all depreciable assets on an annual basis using the
straight-line method. The company expenses a full month of
depreciation in the first month of use.
- EEC expects that it will be able to fully comply with all terms and conditions of the government assistance. It elects to use the net method to report the government aid.
- Assume that all expenses noted in the question are paid in cash.
- While the resulting journal entries will all be entered to the
nearest dollar, EEC rounds all dollar-based calculations to the
nearest whole cent (for example, $21.46) and percentages to two
decimal places (for example, 13.41%). You should do likewise in
your supporting calculations.
Required:
a) Calculate the allocated cost of PPE at April 1, 20X2. Determine
the total depreciation and amortization expense EEC will record for
the 20X2 and 20X3 fiscal years. (Calculate the
depreciation/amortization expense per month for
all depreciable assets.) Calculate the net book value of PPE as at
December 31, 20X2, and December 31, 20X3.
b) Record a summary of the journal entries pertaining to the
identified transactions in the same order as those presented in the
question for both 20X2 and 20X3. Prepare a
separate journal entry for each expenditure and receipt. Ensure
that the journal entries are dated and include a brief description
of the pertinent details. Supporting calculations are to be
referenced or included in the description.
c) Record the year-end adjusting journal entries pertaining to
depreciation and amortization for both 20X2 and
20X3. Ensure that the journal entries are dated and include a brief
description of the pertinent details. Prepare a separate journal
entry pertaining to each asset class. Supporting calculations are
to be referenced or included in the description.